Sort
10,766 grants matching “checkpoint inhibitor”
Project 3: HHLA2 as a THerapeutic Target in RCC
$37,502David McDermott · Beth Israel Deaconess Medical Center · P50 · FY2025 · CA
Epigenetic Regulation by Histone Modifiers in Development and Cancer
$37,440Christie Ching-Lin Sze · Northwestern University At Chicago · F99 · FY2018 · CA
Antibody blockade of T cell activating co-inhibitory receptor KLRG1 for treatment of melanoma
$37,385Stefano Gulla · Abcuro, Inc. · R43 · FY2020 · CA
Divergent response to radio-immunotherapy in HNSCC and PDAC is mediated by regulatory T cells
$37,384Jacob Gadwa · University Of Colorado Denver · F31 · FY2024 · DE
Elucidating the Mechanism of CDK4/6 Inhibitor-Mediated Radiosensitization of ER+ Breast Cancers
$37,324Andrea Michelle Pesch · University Of Michigan At Ann Arbor · F31 · FY2020 · CA
NLR and Oral Cancer Immune Escape
$37,315Blake Heath · University Of Michigan At Ann Arbor · F31 · FY2019 · DE
Polyamines drive glioblastoma progression
$37,225Kristen Kay · Cleveland Clinic Lerner Com-Cwru · F31 · FY2021 · CA
Targeted radionuclide therapy for tumor immunomodulation and enhancing immunotherapy response
$37,196Caroline Paula Anne Kerr · University Of Wisconsin-Madison · F30 · FY2022 · CA
ATM as target for malignant glioma radiosensitization.
$37,096Kristoffer Valerie · Virginia Commonwealth University · R01 · FY2011 · NS
Suppression of translocations by RecQ-like DNA helicases
$37,070Kristina Schmidt · University Of South Florida · R01 · FY2010 · GM
Mechanism of Immune Dysfunction and Morbid Outcomes in Response to Shock/Sepsis
$37,040Alfred Ayala · Rhode Island Hospital · R35 · FY2025 · GM
INTERACTION OF YEAST CHECKPOINT PROTEINS AS DRUG ASSAY
$37,039Emory University · R01 · FY2002 · CA
The Role of SPON1 Expressing Inflammatory Monocytes in Promoting Lung Cancer Metastasis.
$37,027Nisitha Sengottuvel · Univ Of North Carolina Chapel Hill · F30 · FY2020 · CA
MITOCHONDRIA AND APOPTOSIS
$37,024Ryuji Yamaguchi · University Of California, San Diego · P41 · FY2011 · RR
The Role of HIF2 in Pancreatic Ductal Adenocarcinoma
$37,001Albert Koong · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Genomic and Microenvironmental Determinants, Temporal Dynamics, and Treatment Efficacy of Radiation-Based Combination Therapies
$36,982Timothy An-Thy Chan · Cleveland Clinic Lerner Com-Cwru · U54 · FY2023 · CA
Cancer Immunology Program - 03
$36,924Drew M. Pardoll · Johns Hopkins University · P30 · FY2019 · CA
Cancer Immunology Program - 03
$36,924Drew M. Pardoll · Johns Hopkins University · P30 · FY2021 · CA
Cancer Immunology Program - 03
$36,924Drew M. Pardoll · Johns Hopkins University · P30 · FY2020 · CA
Breast and Ovarian Cancer Program - 08
$36,923Vered Stearns · Johns Hopkins University · P30 · FY2020 · CA
Breast and Ovarian Cancer Program - 08
$36,923Vered Stearns · Johns Hopkins University · P30 · FY2019 · CA
Breast and Ovarian Cancer Program - 08
$36,923Vered Stearns · Johns Hopkins University · P30 · FY2021 · CA
Cancer Immunology Program - 03
$36,915Drew M. Pardoll · Johns Hopkins University · P30 · FY2018 · CA
Cancer Immunology Program - 03
$36,868Drew M. Pardoll · Johns Hopkins University · P30 · FY2017 · CA
Epigenetic regulation of metabolic stress pathways in melanoma infiltrating lymphocytes- Resubmission
$36,868Brian Koss · Univ Of Arkansas For Med Scis · F31 · FY2019 · CA